rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Mirion Technologies, Inc.

MIR · NYSE

Health CareLife-science toolsNot moving yet

MIR stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 36 weeks. It is 12.9% below that average now. Life Science Tools & Research Services: 54% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 36
Industry in uptrend
54% +4 in 4 wk
Insider buys, 12 months
$624K
Insider sales, 12 months
$20.5M
Officials’ trades on record
6
Institutions holding
328 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

20 Apr – 19 Oct
27%44%61%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$11.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

6 disclosed lines: House 0, Senate 0, executive 6; 1 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k31 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k29 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k30 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k26 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k26 Jan 2026filed 14 May 2026

Insiders

Buy orders, 12 months1
Sale orders, 12 months6
Buyers · sellers1 · 5
WhoDidSharesTraded
Brian SchopferChief Financial Officerbought20,000at $15.602 Sep 2026filed 2 Sep 2026
Christopher A. MooreChief Accounting Officer (PAO)sold8,400at $19.647 May 2026filed 8 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders328-10 on the quarter
New · exited58 · 66
Reported value$4.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202638,262,307$686.0M+404,610+1.1%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202618,179,850$326.0M+274,128+1.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202610,613,869$190.3M+108,674+1.0%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 202610,406,605$186.6M+3,056,937+41.6%
STATE STREET CORPadded · filed 7 Aug 20269,923,609$177.9M+493,592+5.2%
Alyeska Investment Group, L.P.added · filed 14 Aug 20269,534,955$171.0M+6,833,375+252.9%
COOPERMAN LEON Gunchanged · filed 14 Aug 20268,383,441$150.3M00.0%
FMR LLCadded · filed 13 Aug 20267,329,386$131.4M+777,694+11.9%
CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 20266,685,434$119.9M+5,571,373+500.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20266,280,048$112.6M+339,873+5.7%
31 Mar 2023 – 30 Jun 2026
101216331Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jody Markopoulos Company insiderDirector · last 30 Sep 20260 · 0
Lawrence D. Kingsley Company insiderDirector · last 30 Sep 20260 · 3
Brian Schopfer Company insiderChief Financial Officer · last 2 Sep 20261 · 4
Donald J. Trump Executive branchWhite House Office · last 31 Aug 20263 · 3
John W. Kuo Company insiderDirector · last 13 May 20260 · 0
Kenneth Bockhorst Company insiderDirector · last 13 May 20260 · 0
Robert Cascella Company insiderDirector · last 13 May 20260 · 0
Sheila Rege Company insiderDirector · last 13 May 20260 · 0
Steven W. Etzel Company insiderDirector · last 13 May 20260 · 0
Christopher A. Moore Company insiderChief Accounting Officer (PAO) · last 7 May 20260 · 3
Thomas D. Logan Company insiderChief Executive Officer · last 6 May 20260 · 8
Alison Ulrich Company insiderChief Human Resources Officer · last 1 Apr 20260 · 0

Same industry

OABI OmniAbLeading+67%
TXG 10x GenomicsLeading+59%
AVTR AvantorLeading+45%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+35%
MASS 908 DevicesLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

Awards1
Total$5,869
Latest11 Feb 2025

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202547.4%
Operating profit marginFY 2025 · to 31 Dec 20255.6%
Free cash flow marginFY 2025 · to 31 Dec 202511.6%
Return on capital employedFY 2025 · to 31 Dec 20251.6%
Cash conversionFY 2025 · to 31 Dec 2025498%
Debt to equityFY 2025 · to 31 Dec 20250.24×
Research spendFY 2025 · to 31 Dec 20254.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$412.3M
Free cash flowFY 2025 · to 31 Dec 2025$106.9M

Analyst forecasts

No analyst forecasts yet.